Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's disease mouse model (aged APP/PS1+/-...
Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced it has received approval by the Bellberry Human Research Ethics Committee (HREC) in Australia to initiate...
Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ. The...